Sabra Healthcare REIT (NASDAQ:SBRA) Given New $22.00 Price Target at Cantor Fitzgerald

Sabra Healthcare REIT (NASDAQ:SBRA) had its target price increased by Cantor Fitzgerald from $21.00 to $22.00 in a note issued to investors on Monday,Benzinga reports. The brokerage currently has a “neutral” rating on the real estate investment trust’s stock. Cantor Fitzgerald’s price target would suggest a potential upside of 6.02% from the company’s previous close.

A number of other research firms have also issued reports on SBRA. Weiss Ratings lowered Sabra Healthcare REIT from a “buy (a-)” rating to a “buy (b+)” rating in a research note on Friday, May 1st. Scotiabank boosted their price objective on Sabra Healthcare REIT from $20.00 to $21.00 and gave the company a “sector perform” rating in a research note on Monday, March 2nd. Truist Financial boosted their price objective on Sabra Healthcare REIT from $21.00 to $22.00 and gave the company a “hold” rating in a research note on Friday, March 13th. Citigroup boosted their price objective on Sabra Healthcare REIT from $21.00 to $24.00 and gave the company a “buy” rating in a research note on Wednesday, February 18th. Finally, Wells Fargo & Company boosted their price objective on Sabra Healthcare REIT from $21.00 to $22.00 and gave the company an “overweight” rating in a research note on Thursday, March 26th. Five analysts have rated the stock with a Buy rating and five have issued a Hold rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $22.10.

Sabra Healthcare REIT Stock Performance

NASDAQ:SBRA opened at $20.75 on Monday. The company has a debt-to-equity ratio of 0.96, a quick ratio of 4.72 and a current ratio of 4.72. Sabra Healthcare REIT has a 52-week low of $17.08 and a 52-week high of $21.07. The firm has a market cap of $5.23 billion, a price-to-earnings ratio of 32.94, a PEG ratio of 1.66 and a beta of 0.67. The business’s fifty day moving average is $20.24 and its 200 day moving average is $19.41.

Sabra Healthcare REIT (NASDAQ:SBRA) last released its quarterly earnings data on Wednesday, April 29th. The real estate investment trust reported $0.16 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.16. Sabra Healthcare REIT had a return on equity of 5.60% and a net margin of 19.22%.The company had revenue of $221.75 million for the quarter, compared to analyst estimates of $209.20 million. During the same period in the previous year, the company posted $0.37 EPS. The firm’s revenue for the quarter was up 20.9% compared to the same quarter last year. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. Research analysts predict that Sabra Healthcare REIT will post 1.5 EPS for the current year.

Hedge Funds Weigh In On Sabra Healthcare REIT

Institutional investors have recently added to or reduced their stakes in the business. Rothschild Investment LLC increased its stake in Sabra Healthcare REIT by 164.6% in the 4th quarter. Rothschild Investment LLC now owns 1,429 shares of the real estate investment trust’s stock worth $27,000 after acquiring an additional 889 shares during the last quarter. Smartleaf Asset Management LLC increased its stake in Sabra Healthcare REIT by 97.7% in the 4th quarter. Smartleaf Asset Management LLC now owns 1,445 shares of the real estate investment trust’s stock worth $27,000 after acquiring an additional 714 shares during the last quarter. Founders Capital Management bought a new position in Sabra Healthcare REIT in the 3rd quarter worth about $28,000. Strengthening Families & Communities LLC bought a new position in Sabra Healthcare REIT in the 4th quarter worth about $29,000. Finally, Danske Bank A S bought a new position in Sabra Healthcare REIT in the 3rd quarter worth about $30,000. 99.40% of the stock is currently owned by institutional investors.

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net?lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long?term, triple?net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post?acute rehabilitation and research and development laboratories.